Does BRODALUMAB Cause Nephrolithiasis? 15 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Nephrolithiasis have been filed in association with BRODALUMAB (Siliq). This represents 0.7% of all adverse event reports for BRODALUMAB.
15
Reports of Nephrolithiasis with BRODALUMAB
0.7%
of all BRODALUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Nephrolithiasis From BRODALUMAB?
Of the 15 reports, 4 (26.7%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRODALUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does BRODALUMAB Cause?
Psoriasis (418)
Drug ineffective (177)
Arthralgia (175)
Fatigue (152)
Psoriatic arthropathy (141)
Intentional product use issue (136)
Headache (126)
Therapy interrupted (126)
Product dose omission issue (124)
Disease recurrence (118)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which BRODALUMAB Alternatives Have Lower Nephrolithiasis Risk?
BRODALUMAB vs BROLUCIZUMAB
BRODALUMAB vs BROLUCIZUMAB-DBLL
BRODALUMAB vs BROMAZEPAM
BRODALUMAB vs BROMFENAC
BRODALUMAB vs BROMHEXINE